Journal
NEURON
Volume 57, Issue 5, Pages 680-690Publisher
CELL PRESS
DOI: 10.1016/j.neuron.2008.02.024
Keywords
-
Categories
Funding
- NIA NIH HHS [AG18884, P01 AG017216, R01 AG018379, R01 AG018884, AG172116, P01 AG017216-020004, AG18379] Funding Source: Medline
- NINDS NIH HHS [P01 NS048447, NS48447, P01 NS048447-030005] Funding Source: Medline
Ask authors/readers for more resources
Cyclin-dependent kinase 5 (cdk5) has been implicated in Alzheimer's disease (AD) pathogenesis. Here, we demonstrate that overexpression of p25, an activator of cdk5, led to increased levels of BACE1 mRNA and protein in vitro and in vivo. A p25/cdk5 responsive region containing multiple sites for signal transducer and activator of transcription (STAT1/3) was identified in the BACE1 promoter. STAT3 interacts with the BACE1 promoter, and p25-overexpressing mice had elevated levels of pSTAT3 and BACE1, whereas cdk5-deficient mice had reduced levels. Furthermore, mice with a targeted mutation in the STAT3 cdk5 responsive site had lower levels of BACE1. Increased BACE levels in p25 overexpressing mice correlated with enhanced amyloidogenic processing that could be reversed by a cdk5 inhibitor. These data demonstrate a pathway by which p25/cdk5 increases the amyloidogenic processing of APP through STAT3-mediated transcriptional control of BACE1 that could have implications for AD pathogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available